Fennec Pharma falls on surprise Q4 loss
** Drugmaker Fennec Pharmaceuticals' FENC.O shares down 11.7% at $6.07 ** Co posts quarterly net loss of 6 cents per share compared to analysts' estimate of profit of 17 cents per share, according to data compiled by LSEG ** Co also reports fourth-quarter product sales of $7.93 million, missing analysts' estimate of $16.72 million ** Up to last close, FENC has fallen 28.4% in the past 12 months (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))
Recent news on Fennec Pharmaceuticals
See all newsFennec Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a share - Earnings Preview
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple